OR WAIT null SECS
March 11, 2022
SCG Cell Therapy has signed a collaboration agreement with A*STAR’s BTI to advance the development of antibodies for infectious diseases and cancer treatments.
Novartis will pay Voyager up to $1.75 billion for access to Voyager’s novel Tracer AAV capsids for potential use with three CNS targets.
March 10, 2022
Novo Nordisk will expand its existing research collaboration in novel delivery technologies with MIT and Brigham and Women’s Hospital.
UCB has announced it will build a new innovative gene therapy facility in Belgium.
March 08, 2022
Amgen has announced the groundbreaking of its newest biomanufacturing facility in North Carolina.
Johnson & Johnson have announced a landmark agreement to enable the manufacturing and availability of its COVID-19 vaccine in Africa by an African company.
Oculis has gained exclusive global rights to neuroprotective drug candidate for glaucoma through a licensing agreement with Accure Therapeutics.
Moderna has announced that it has entered a Memorandum of Understanding with the government of the Republic of Kenya to establish its first mRNA manufacturing facility in Africa.
March 07, 2022
Researchers at McGill University have made advancements with a novel method for growing synthetic bone tissue.
March 04, 2022
Genoox will use their genomic data platform to validate Element's AVITI system.